Legal & General Group
TNGX icon

Legal & General Group’s Tango Therapeutics TNGX Stock Holding History

Legal & General Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
85,642
+50,267
+142% +$1.24M ﹤0.01% 1849
2026
Q1 		$740K Sell
35,375
-4,055
-10% -$56.4K ﹤0.01% 2241
2025
Q4 		$349K Buy
39,430
+32,985
+512% +$284K ﹤0.01% 2505
2025
Q3 		$54.1K Sell
6,445
-540
-8% -$3.65K ﹤0.01% 2717
2025
Q2 		$35.8K Buy
6,985
+1,640
+31% +$4.05K ﹤0.01% 2784
2025
Q1 		$7.32K Sell
5,345
-32,616
-86% -$80.1K ﹤0.01% 3225
2024
Q4 		$117K Hold
37,961
– – ﹤0.01% 2709
2024
Q3 		$292K Sell
37,961
-120
-0.3% -$1.15K ﹤0.01% 2614
2024
Q2 		$327K Buy
38,081
+1,674
+5% +$12.9K ﹤0.01% 2571
2024
Q1 		$289K Hold
36,407
– – ﹤0.01% 2613
2023
Q4 		$360K Sell
36,407
-3,515
-9% -$30.5K ﹤0.01% 2573
2023
Q3 		$450K Sell
39,922
-652
-2% -$3.98K ﹤0.01% 2478
2023
Q2 		$135K Buy
40,574
+21,883
+117% +$78.7K ﹤0.01% 2807
2023
Q1 		$73.8K Buy
18,691
+1,223
+7% +$7.1K ﹤0.01% 2820
2022
Q4 		$127K Buy
17,468
+5,889
+51% +$41.4K ﹤0.01% 2760
2022
Q3 		$42K Buy
11,579
+3,935
+51% +$16.8K ﹤0.01% 3015
2022
Q2 		$35K Sell
7,644
-3,753
-33% -$22.7K ﹤0.01% 3078
2022
Q1 		$86K Hold
11,397
– – ﹤0.01% 2902
2021
Q4 		$125K Buy
+11,397
New +$137K ﹤0.01% 2861

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Legal & General Group's TNGX Position: Q2 2026 in Review

Legal & General Group increased its Tango Therapeutics (TNGX) stake by 142% in Q2 2026, buying an estimated $1.24M and bringing the position to 85,642 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

Legal & General Group first reported a position in TNGX in Q4 2021 and has held it in 19 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Legal & General Group held 85,642 shares of Tango Therapeutics worth $2.68M as of Q2 2026.
  • Legal & General Group bought 50,267 Tango Therapeutics shares in Q2 2026, an estimated $1.24M.
  • Tango Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1849 holding.
  • Legal & General Group first reported a position in Tango Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.